If we are ever to find an effective treatment for Alzheimer's disease we need the participation of every member of the Alzheimer's community.
I cannot emphasize enough how much we need you.
Clinical Research Depends on People Like Us
The clinical trial sponsor is seeking people who are experiencing symptoms from Alzheimer’s disease, such as problems with memory or thinking clearly.
A Quick Personal Note from Bob DeMarco
My mother and I participated in a clinical trial for Alzheimer's disease. It was a wonderful experience for both of us. I can't tell you how much the significant memory testing, and detailed medical attention you receive means. It certainly helped relieve many of my worries at the time. The only way we can beat Alzheimer's is by getting greater participation in clinical trials from people like you and me.
More than 150 Alzheimer's and related clinical trials in the United States are looking for volunteers. At least 70,000 people with Alzheimer's, healthy volunteers, and caregivers are urgently needed. - National Institutes of Health (NIH)
Quick Link - Go directly to the clinical trial page - If you are interested in this clinical trial the easiest way to participate is by filling out a quick questionnaire. This will determine if you pre-qualify.
If you do pre-qualify, you will be contacted by a nurse, and if everything is in order - you will receive a referral to a clinical trial office near you. All information is covered by the Privacy Act.
How you can BENEFIT from participation in a clinical trial:
- You may get a new treatment for a disease before it is available to everyone.
- You play a more active role in the health care and testing of your loved one.
- You will receive high quality medical care and more frequent health check-ups as part of your participation.
- You will be actively participating in the search for a cure for Alzheimer's disease.
About experiment drug Lu AE58054 for Alzheimer's disease.
- Lu AE58054 is a selective 5-HT6 receptor antagonist under investigation for the treatment of Alzheimer's disease. This is an experimental drug that is now being tested in a Phase III clinical trial.
- The 5-HT6 receptor is a different approach from the amyloid and tau hypotheses that have underpinned much of the research to date on Alzheimer’s disease.
- The phase II clinical study demonstrated that treatment with Lu AE58054 and donepezil (Aricept) for six months improved cognitive performance in patients with moderate Alzheimer’s disease.
- All study-related medicines and consultations specific to the study will be free of charge and reasonable travel, parking and food expenses will be paid.
- The patient may continue to see their regular doctor while participating in this study.
- A high standard of study-related medical care will be provided.
- Patients may help to advance a potential new treatment for mild to moderate Alzheimer’s disease.
- Patient may have an opportunity to continue in a 6-month extension.
You are reading original content the Alzheimer's Reading Room